Novartis case: a blow to AIDS treatment? (in Englisch)
The pharmaceutical giant filed a case with an Indian high court challenging patent laws.
The humanitarian agency Medecins Sans Frontieres is warning that tens of thousands of people being treated for AIDS will suffer if Swiss drugmaker Novartis succeeds in changing India's patent law. The pharmaceutical giant filed a case with an Indian high court challenging the country’s new patent laws. MSF has launched a global petition to pressure the company to withdraw the case. In fact, India did not allow the patenting of drugs until 2005, when it joined the World Trade Organization. Tido von Schoen-Angerer, director of MSF’s Campaign for Access to Essential Medicines, talks about the impact the turning over of specific provisions of India’s patent law could have on the global fight against HIV/AIDS.
Das Interview wurde am 30. Januar 2007 gesendet.